Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.970
+0.010 (0.51%)
At close: Jan 7, 2026, 4:00 PM EST
1.961
-0.009 (-0.45%)
After-hours: Jan 7, 2026, 7:46 PM EST
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $28.15 million as of January 7, 2026. Its market cap has increased by 1.62% in one year.
Market Cap
28.15M
Enterprise Value
8.01M
1-Year Change
1.62%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $28.15M, a decrease of -71.28%. That is a compound annual growth rate of -10.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 28.00M | 1.45% |
| Dec 31, 2025 | 27.60M | 1.85% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
| Apr 10, 2014 | 98.00M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |